Patents by Inventor Yong Qian
Yong Qian has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20190343736Abstract: The present invention, belonging to the technical field of chemical sun-screening agent preparation, discloses a high-ultraviolet absorption lignin/chemical sun-screening agent microcapsule using lignin as a wall material and a preparation method therefor. The method of the present invention comprises the following steps: (1) dissolving 1-20 parts by weight of lignin in 100-200 parts by weight of an aqueous solution with a pH of 12, adjusting the pH of the solution to 7-10, and then removing insoluble substances by filtration to obtain a lignin solution; and (2) mixing 10-50 parts by weight of the lignin solution in step (1) with 1-10 parts by weight of a chemical sun-screening agent, and performing ultrasonic radiation under a power of 200-1500 W for 10 s to 25 min to obtain a lignin/chemical sun-screening agent microcapsule emulsion.Type: ApplicationFiled: November 21, 2017Publication date: November 14, 2019Applicant: SOUTH CHINA UNIVERSITY OF TECHNOLOGYInventors: Xueqing QIU, Yong QIAN, Ying LI, Dongjie YANG, Hongming LOU, Shiping ZHU, Weifeng LIU
-
Publication number: 20190311468Abstract: A system and method for filling light for video images are provided. The method may include: obtaining, by at least one video processing device, a first image including a plurality of reference pixels and is associated with at least one brightness direction; for each of the plurality of reference pixels, obtaining, by the at least one video processing device, a reference brightness value; identifying, by the at least one video processing device, a target brightness direction from the at least one brightness direction; for each of the plurality of reference pixels, determining a brightness enhancement multiplier for the reference pixel based on the plurality of reference brightness values and locations of the plurality of reference pixels along the target brightness direction of the first image; and modifying, by the at least one video processing device, brightness of the first image at least based on the brightness enhancement multipliers.Type: ApplicationFiled: June 21, 2019Publication date: October 10, 2019Applicant: ZHEJIANG DAHUA TECHNOLOGY CO., LTD.Inventors: Yong QIAN, Junjun YU, Wei FANG
-
Publication number: 20190291081Abstract: A three-dimensional lignin porous carbon/zinc oxide composite material and its preparation and application in the field of photocatalysis are disclosed. The method includes preparing a lignin/zinc oxide precursor composite by a hydrothermal method from a zinc salt, a weak alkali salt and an industrial lignin, and preparing a three-dimensional lignin porous carbon/zinc oxide composite material by high temperature calcination of the lignin/zinc oxide precursor composite. The composite material has a regular three-dimensional pore structure, with zinc oxide nanoparticles uniformly embedded among the three-dimensional lignin porous carbon nanosheets. Application of the composite material to the field of photocatalysis, especially as a photocatalyst for photocatalytic degradation of organic dye pollutants, can significantly improve the degradation efficiency and rate, and has potential application value in the field of photocatalytic degradation of organic pollutants.Type: ApplicationFiled: November 16, 2017Publication date: September 26, 2019Inventors: Dongjie Yang, Huan Wang, Xueqing Qiu, Hongming Lou, Weifeng Liu, Yong Qian, Xinping Ouyang, Sisi Wen
-
Patent number: 10314794Abstract: The invention relates to a drug sustained-release composition, particularly a sustained-release composition comprising metoprolol and preparation method thereof. The invention also relates to a combination product comprising a sustained-release composition comprising metoprolol and a pharmaceutical composition comprising hydrochlorothiazide. The sustained-release composition comprising metoprolol according to the invention eliminates the phenomena of delayed release of such sustained-release compositions in the prior art, has a better drug release curve, and also have the advantages such as simple formula, easy operation, stable quality, strong controllability, and good reproducibility, and therefore have good application prospects.Type: GrantFiled: June 23, 2015Date of Patent: June 11, 2019Assignee: Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. ChinaInventors: Chunsheng Gao, Yuli Wang, Meiyan Yang, Li Shan, Jingjing Dai, Yong Qian, Yan Qiu
-
Patent number: 9894117Abstract: In an example embodiment, a virtual conference is established with a server and a plurality of endpoint devices. One endpoint device, acting as a sender, may transfer a file to N other endpoint devices, acting as receivers. The sender divides the file in at least N segments and delivers one segment to each receiver. Receivers then request the next desired segment from one or more devices containing that segment. If devices hold the segment, the segment may be divided into parts, and one part may be requested from each device.Type: GrantFiled: October 9, 2013Date of Patent: February 13, 2018Assignee: Cisco Technology, Inc.Inventors: Haihua Huang, Jianping Shen, Yong Qian, Kejun Xia
-
Patent number: 9887892Abstract: Provided by the present disclosure are a traffic statistics collection method and device. In the method, one and the same counter is adopted to set an input control parameter for each type of message in N types of messages respectively; N count values are acquired from the counter when a first preset moment is reached, wherein the N count values include: a total number count of the N types of messages and N?1 input control parameter counts, which are received by a preset port at the first preset moment; and statistics are collected for traffic, at the first preset moment, of the each type of message in the N types of messages through the N input control parameters and the N count values respectively, thereby saving counter resources.Type: GrantFiled: April 25, 2014Date of Patent: February 6, 2018Assignee: XI'AN ZHONGXING NEW SOFTWARE CO. LTD.Inventors: Yinkui Cheng, Yong Qian
-
Patent number: 9851390Abstract: A method for detecting and locating faulty line on the distribution network circuit based on full waveform information, which uses the current data on the fault occurrence and whole-process operation of the compensation device to effectively solve such common problems as low fault current, poor reliability and low sensitivity in case of single-phase grounding fault to the low-current system through precise GPS synchronization. It improves the sensitivity and reliability of the grounding fault detection, which does not interfere with the system and is applicable to high-resistance grounding.Type: GrantFiled: October 31, 2014Date of Patent: December 26, 2017Assignee: SHANGHAI JIAO TONG UNIVERSITYInventors: Yadong Liu, Gehao Sheng, Jiejie Dai, Jiamei Liu, Yun Hu, Xiaolei Xie, Yong Qian, Yue Hu, Xiuchen Jiang
-
Publication number: 20170258883Abstract: Disclosed is a method of making a proteinase-engineered cancer vaccine or cancer-cell-derived spheres for treating a cancer patient, especially for cancer patients at advanced/metastatic stage. The cancer vaccine comprises dead cancer-cell-derived spheres with unbroken plasma membrane wherein the extracellular proteins and extracellular portion of membrane proteins are cleaved by proteinase digestion. The cancer vaccine may be derived from cancer cell lines or patients' cancer cells or derivatives. Also disclosed is a method of treating a cancer patient by administrating an effective amount of the cancer vaccine or cancer-cell-derived spheres to the patient. The present invention further provides a method of treating multiple diseases in addition to cancers by the cancer-cell-derived spheres, and obtaining cancer-specific immune components from blood of individuals treated with the cancer-cell-derived spheres.Type: ApplicationFiled: May 19, 2017Publication date: September 14, 2017Inventor: Yong Qian
-
Patent number: 9738612Abstract: Disclosed are a use of a methylacryloyl benzimidazolone derivative, an optical isomer or a pharmaceutically acceptable salt or prodrug thereof in the preparation of: (a) a pharmaceutical composition or reagent for down-regulating the activity of PI3K/Akt pathways; (b) a pharmaceutical composition or reagent for treating or inhibiting a tumour; and/or inhibiting tumour cell growth; and/or (c) a pharmaceutical composition or reagent for blocking the cell cycle. The compounds involved in the present invention can down-regulate the level of Akt phosphorylation in P13K/Akt signaling pathways, and the functional effects of the compounds are equivalent to those of a novel small-molecular targeting drug MK2206; while the research at the cellular level has found that the methylacryloyl benzimidazolone derivatives represented by FD1 have a good proliferation inhibiting effect on tumour cells. What is different from MK2206 is that FD1 has better effects on a PTEN deleted cell.Type: GrantFiled: March 23, 2015Date of Patent: August 22, 2017Assignees: Shanghai Nature Standard R&D and Biotech Co., Ltd, Shanghai Standard Technology Co., Ltd., Shanghai Founder Biomed R&D Co., Ltd.Inventors: Jiapeng Li, Zhiqin Ji, Xiaoya Zhou, Shaopeng Wei, Yong Qian, Tianpei Xie
-
Patent number: 9684199Abstract: A liquid crystal display device includes a first substrate, a second substrate, and a liquid crystal layer. The first substrate includes a first transparent substrate including a first surface and a second surface, a color filter layer formed on the first surface of the first transparent substrate, a first alignment film formed on the color filter layer, and a first electrode interlayered in the color filter layer. The second substrate includes a second transparent substrate comprising a third surface and a fourth surface, a second electrode and a third electrode formed on the third surface of the second transparent substrate sequentially, and a second alignment film is formed on the third electrode. The second electrode and the third electrode are arranged at different insulation layers respectively and electrically insulated with each other. The LCD device of the present invention has an improved transmittance and a fast response time.Type: GrantFiled: September 22, 2013Date of Patent: June 20, 2017Assignee: INFOVISION OPTOELECTRONICS (KUNSHAN) CO., LTD.Inventors: Te-Chen Chung, Tean-Sen Jen, Chia-Te Liao, Yong-qian Li, Hong-qing Cui, Jin-yu Li, Dong-zhao Li
-
Patent number: 9669082Abstract: The present invention provides a method of making a proteinase-engineered cancer vaccine for treating a cancer patient, especially for cancer patient at advanced/metastatic stage. The cancer vaccine comprises dead cancer cells with unbroken plasma membrane wherein the extracellular proteins and extracellular portion of membrane proteins are cleaved by proteinase digestion. The cancer vaccine may be derived from cancer cell lines or patients' cancer cells. The present invention provides a method of treating a cancer patient by administrating an effective amount of the cancer vaccine to the patient. In a clinical trial with 35 cancer patients, the cancer vaccine therapy brings cancer-free lives (no detectable tumor, micro tumor or cancer cells after treatments of customized cancer vaccines) back to 40% of these patients. The present invention further provides a method of obtaining cancer-specific immune components from blood of individuals treated with the cancer vaccine.Type: GrantFiled: January 11, 2015Date of Patent: June 6, 2017Inventor: Yong Qian
-
Publication number: 20170144976Abstract: Disclosed are a use of a methylacryloyl benzimidazolone derivative, an optical isomer or a pharmaceutically acceptable salt or prodrug thereof in the preparation of: (a) a pharmaceutical composition or reagent for down-regulating the activity of PI3K/Akt pathways; (b) a pharmaceutical composition or reagent for treating or inhibiting a tumour; and/or inhibiting tumour cell growth; and/or (c) a pharmaceutical composition or reagent for blocking the cell cycle. The compounds involved in the present invention can down-regulate the level of Akt phosphorylation in P 13K/Akt signaling pathways, and the functional effects of the compounds are equivalent to those of a novel small-molecular targeting drug MK2206; while the research at the cellular level has found that the methylacryloyl benzimidazolone derivatives represented by FD1 have a good proliferation inhibiting effect on tumour cells. What is different from MK2206 is that FD1 has better effects on a PTEN deleted cell.Type: ApplicationFiled: March 23, 2015Publication date: May 25, 2017Inventors: Jiapeng LI, Zhiqin JI, Xiaoya ZHOU, Shaopeng WEI, Yong QIAN, Tianpei XIE
-
Publication number: 20170119701Abstract: The invention relates to a drug sustained-release composition, particularly a sustained-release composition comprising metoprolol and preparation method thereof. The invention also relates to a combination product comprising a sustained-release composition comprising metoprolol and a pharmaceutical composition comprising hydrochlorothiazide. The sustained-release composition comprising metoprolol according to the invention eliminates the phenomena of delayed release of such sustained-release compositions in the prior art, has a better drug release curve, and also have the advantages such as simple formula, easy operation, stable quality, strong controllability, and good reproducibility, and therefore have good application prospects.Type: ApplicationFiled: June 23, 2015Publication date: May 4, 2017Applicant: Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. ChinaInventors: Chunsheng GAO, Yuli WANG, Meiyan YANG, Li SHAN, Jingjing DAI, Yong QIAN, Yan QIU
-
Publication number: 20170085606Abstract: According to one embodiment, a technique is presented to dynamically adjust a sample period used at a presenter device for a screen content capture sharing function during a communication session. In another embodiment, a technique is provided to control how frames of screen capture content, e.g., in a desktop sharing function, are sent to attendee devices during an online conference session. According to a still another embodiment, a technique is provided to enable on-demand designation of frames as key-frames during a desktop sharing function of an online conference session.Type: ApplicationFiled: December 1, 2016Publication date: March 23, 2017Inventors: Haihua Huang, Yong Qian, Kejun Xia, Yaqing Zhang
-
Patent number: 9596130Abstract: The disclosure provides a method and system for link switching. The method includes: acquiring a warning message, wherein the warning message is sent via broadcast or multicast by a line card where a failure of a link occurs; executing link switching according to the warning message. Through the technical solutions provided by the disclosure, the efficiency of the link switching in a distributed system is improved.Type: GrantFiled: December 6, 2013Date of Patent: March 14, 2017Assignee: ZTE CORPORATIONInventors: Chunlei Chen, Yong Qian
-
Patent number: 9549006Abstract: According to one embodiment, a technique is presented to dynamically adjust a sample period used at a presenter device for a screen content capture sharing function during a communication session. In another embodiment, a technique is provided to control how frames of screen capture content, e.g., in a desktop sharing function, are sent to attendee devices during an online conference session. According to a still another embodiment, a technique is provided to enable on-demand designation of frames as key-frames during a desktop sharing function of an online conference session.Type: GrantFiled: July 31, 2013Date of Patent: January 17, 2017Assignee: Cisco Technology, Inc.Inventors: Haihua Huang, Yong Qian, Kejun Xia, Yaqing Zhang
-
Patent number: 9515970Abstract: Techniques are provided for delivering messages to users of client devices in a network. At a server device in a network, location information of each of a plurality of client devices is obtained. Each of the client devices runs a presence application for a user in the network and is configured to log-in with one or more resources. A message is received from a sender device in the network. The message is intended to be presented to the user via the presence application and one or more of the resources. Based on the location information of the client devices, one or more designated client devices are selected to which the message is to be sent such that the message is presented to the user via the presence application running on the one or more designated client devices and via one or more of the resources.Type: GrantFiled: July 17, 2013Date of Patent: December 6, 2016Assignee: Cisco Technology, Inc.Inventors: Haihua Huang, Yong Qian, Zhao Jiayu, Kejun Xia
-
Patent number: 9462016Abstract: In a sharing session between a presenter and several attendees, the presenter can share any type of document quickly and without substantial prior preparation. The presenter's device identifies an active document-sharing window within the desktop sharing environment, and detects if there is a shared document in the active window. The presenter's device creates a framework for any detected shared document that is transmitted to each of the attendee devices. The framework contains information about the pages in the shared document, such that an attendee device can request a specific page in the shared document. At least the first page of the shared document is rendered to a page image and transmitted to the attendee devices. Upon request from an attendee device, page images of any of the remaining pages may be sent to the attendee device, allowing each attendee to view a different page than the presenter.Type: GrantFiled: August 20, 2013Date of Patent: October 4, 2016Assignee: Cisco Technology, Inc.Inventors: Haihua Huang, Hua Ouyang, Ling Chen, Jun Xiao, Dapeng Sun, Yong Qian
-
Publication number: 20160187406Abstract: A method for identifying a lightning fault of an overhead transmission line (OTL) comprising determining a polarity of a travelling wave of each of three ABC phases subsequent to a single phase outage of the OTL. If the polarity of each phase is the same, the outage is a lightning fault and its type a back flashover; if not the same, proceed to the second step to determine a current change rate R of the fault phase. If R is larger than a threshold value, the outage is a lightning fault and its type a shielding failure; otherwise, the outage is a single-phase grounding fault. A system for identifying the lightning fault which comprises successively at least a group of fault detectors, a wireless communication module, a remote monitoring master station which adopts the above method to determine the fault type of the overhead transmission line.Type: ApplicationFiled: March 16, 2015Publication date: June 30, 2016Inventors: Yadong LIU, Gehao Sheng, Yong Qian, Yue Hu, Xiuchen Jiang
-
Publication number: 20160134496Abstract: Provided by the present disclosure are a traffic statistics collection method and device. In the method, one and the same counter is adopted to set an input control parameter for each type of message in N types of messages respectively; N count values are acquired from the counter when a first preset moment is reached, wherein the N count values include: a total number count of the N types of messages and N?1 input control parameter counts, which are received by a preset port at the first preset moment; and statistics are collected for traffic, at the first preset moment, of the each type of message in the N types of messages through the N input control parameters and the N count values respectively, thereby saving counter resources.Type: ApplicationFiled: April 25, 2014Publication date: May 12, 2016Inventors: Yinkui CHENG, Yong QIAN